These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28539357)

  • 61. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
    Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men.
    Fizelova M; Miilunpohja M; Kangas AJ; Soininen P; Kuusisto J; Ala-Korpela M; Laakso M; Stančáková A
    Atherosclerosis; 2015 May; 240(1):272-7. PubMed ID: 25818853
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
    Kozlitina J; Smagris E; Stender S; Nordestgaard BG; Zhou HH; Tybjærg-Hansen A; Vogt TF; Hobbs HH; Cohen JC
    Nat Genet; 2014 Apr; 46(4):352-6. PubMed ID: 24531328
    [TBL] [Abstract][Full Text] [Related]  

  • 65. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Magkos F; Patterson BW; Mittendorfer B
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1243-9. PubMed ID: 16835398
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
    Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Type 2 diabetes sex-specific effects associated with E167K coding variant in
    Fan Y; Wolford BN; Lu H; Liang W; Sun J; Zhou W; Rom O; Mahajan A; Surakka I; Graham SE; Liu Z; Kim H; Ramdas S; Fritsche LG; Nielsen JB; Gabrielsen ME; Hveem K; Yang D; Song J; Garcia-Barrio MT; Zhang J; Liu W; Zhang K; Willer CJ; Chen YE
    iScience; 2021 Nov; 24(11):103196. PubMed ID: 34746691
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    Lisboa QC; Nardelli MJ; Pereira PA; Miranda DM; Ribeiro SN; Costa RSN; Versiani CA; Vidigal PVT; Ferrari TCA; Couto CA
    World J Hepatol; 2020 Oct; 12(10):792-806. PubMed ID: 33200017
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men.
    Stančáková A; Paananen J; Soininen P; Kangas AJ; Bonnycastle LL; Morken MA; Collins FS; Jackson AU; Boehnke ML; Kuusisto J; Ala-Korpela M; Laakso M
    Diabetes; 2011 May; 60(5):1608-16. PubMed ID: 21421807
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
    Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
    Paternostro R; Staufer K; Traussnigg S; Stättermayer AF; Halilbasic E; Keritam O; Meyer EL; Stift J; Wrba F; Sipos B; Canbay A; Schlattjan M; Aigner E; Datz C; Stickel F; Schafmayer C; Hampe J; Buch S; Prager G; Munda P; Mandorfer M; Ferenci P; Trauner M
    Hepatol Int; 2021 Aug; 15(4):922-933. PubMed ID: 34076851
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men.
    Chan DC; Watts GF; Wang J; Hegele RA; van Bockxmeer FM; Barrett PH
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):45-51. PubMed ID: 18031309
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
    Scorletti E; West AL; Bhatia L; Hoile SP; McCormick KG; Burdge GC; Lillycrop KA; Clough GF; Calder PC; Byrne CD
    J Hepatol; 2015 Dec; 63(6):1476-83. PubMed ID: 26272871
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of gender, age and menopausal status on serum apolipoprotein concentrations.
    Anagnostis P; Stevenson JC; Crook D; Johnston DG; Godsland IF
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):733-740. PubMed ID: 27086565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genotype rs8099917 near the IL28B gene and amino acid substitution at position 70 in the core region of the hepatitis C virus are determinants of serum apolipoprotein B-100 concentration in chronic hepatitis C.
    Aizawa Y; Yohizawa K; Aida Y; Ishiguro H; Abe H; Tsubota A
    Mol Cell Biochem; 2012 Jan; 360(1-2):9-14. PubMed ID: 21879313
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
    Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
    Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.
    Marston NA; Giugliano RP; Melloni GEM; Park JG; Morrill V; Blazing MA; Ference B; Stein E; Stroes ES; Braunwald E; Ellinor PT; Lubitz SA; Ruff CT; Sabatine MS
    JAMA Cardiol; 2022 Mar; 7(3):250-256. PubMed ID: 34773460
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis.
    Liu Z; Que S; Zhou L; Zheng S; Romeo S; Mardinoglu A; Valenti L
    Sci Rep; 2017 Aug; 7(1):9273. PubMed ID: 28839198
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study).
    Käräjämäki AJ; Hukkanen J; Kauma H; Kesäniemi YA; Ukkola O
    Scand J Clin Lab Invest; 2020; 80(2):106-113. PubMed ID: 31851849
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.